drugset / Trial / NCT00153868
A Web-based Study of Quality of Life Benefits Associated Aranesp in Anemic Patients With Cancer
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is a web-based pilot study to evaluate the association between the treatment of anemia with darbepoetin alfa (aranesp) and the clinical benefits in symptom palliation, improved functional status and quality of life in patients with cancer. The feasibility of web-based assessments and data capture will be evaluated.
Timeline
- Start
- 2003-10
- Primary completion
- 2007-08-17
- Completion
- 2007-08-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Darbepoetin alfa | Protein / enzyme biologic | 200 ug | Subcutaneous |
| Comparator | Darbepoetin alfa | Protein / enzyme biologic | 300 ug | Subcutaneous |
| Comparator | Darbepoetin alfa | Protein / enzyme biologic | 500 ug | Subcutaneous |